A new editorial paper was published in Oncotarget’s Volume 15 on July 2, 2024, entitled, “Using early on-treatment circulating tumor DNA measurements as response assessment in metastatic castration resistant prostate cancer.”
Should Every ACL Get E-Stim? What the New NMES Meta-Analysis Really Shows
New meta-analysis: Early NMES after ACL surgery boosts quad strength. When and how should sports PTs use it? We break